Scholars Central

EditorialPublished 2017

HLA-G: A Versatile Biomarker

Authors: Mugdha Vasireddi

Biomarkers Journal

Volume 3 · Issue 1

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

HLA-G is a non-classical MHC Class I molecule that is usually restricted to cytotrophoblasts and other fetal cells in order to protect the fetus from maternal immune responses. However, HLA-G is expressed during viral infections and cancer. The presence of soluble HLA-G, sHLA-G, in serum is noted in various instances of human diseases. Serum HLA-G can serve as a biomarker, which makes it a unique tool in developing confirmatory diagnostics for infectious diseases and cancer. An accurate and early diagnosis of deadly diseases is really important for an early intervention or treatment. The immunosuppressive capabilities of HLA-G make it not only a biomarker for diagnosis but also an excellent target for developing therapeutics. Here, I discuss HLA-G’s potential to be an invaluable tool as a biomarker for diagnostics and a target for therapeutics.

Keywords

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Biomarkers Journal.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalBiomarkers Journal
  • SubjectPathology & Lab Medicine
  • BylineArticles whose byline prints “Mugdha Vasireddi”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels